Related references
Note: Only part of the references are listed.The prognostic and predictive value of serum CA19.9 in pancreatic cancer
J. L. Humphris et al.
ANNALS OF ONCOLOGY (2012)
Surveillance of Pancreatic Cancer Patients after Surgical Resection
Kristin M. Sheffield et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Hospital and Medical Care Days in Pancreatic Cancer
Casey A. Boyd et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
The Glasgow Prognostic Score as a Predictor of Survival in Patients with Potentially Resectable Pancreatic Adenocarcinoma
Marco La Torre et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Costs and Trends in Pancreatic Cancer Treatment
Caitriona B. O'Neill et al.
CANCER (2012)
Loco-recurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy
Yaojun Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Surveillance Computed Tomography Imaging and Detection of Relapse in Intermediate- and Advanced-Stage Pediatric Hodgkin's Lymphoma: A Report From the Children's Oncology Group
Stephan D. Voss et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma
Teiichi Sugiura et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2012)
Pancreatic Adenocarcinoma, Version 2.2012 Featured Updates to the NCCN Guidelines
Margaret A. Tempero et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2012)
Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
Sherif R. Z. Abdel-Misih et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
EBM-based Clinical Guidelines for Pancreatic Cancer 2009 From the Japan Pancreas Society: A Synopsis
Koji Yamaguchi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Medically Managed Hypercholesterolemia and Insulin-Dependent Diabetes Mellitus Preoperatively Predicts Poor Survival after Surgery for Pancreatic Cancer
Ryaz B. Chagpar et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
Hedy Lee Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma
A. Van den Broeck et al.
EJSO (2009)
Prognostic Factors After Resection of Pancreatic Cancer
Michio Ueda et al.
WORLD JOURNAL OF SURGERY (2009)
The Impact of Resection Margin Status and Postoperative CA19-9 Levels on Survival and Patterns of Recurrence After Postoperative High-Dose Radiotherapy With 5-FU-Based Concurrent Chemotherapy for Resectable Pancreatic Cancer
Timothy J. Kinsella et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Elevation of Carbohydrate Antigen 19.9 in Benign Hepatobiliary Conditions and Its Correlation with Serum Bilirubin Concentration
S. L. Ong et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Preventive care for colorectal cancer survivors: A 5-year longitudinal study
Claire F. Snyder et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Postresection CA 19-9 Predicts Overall Survival in Patients With Pancreatic Cancer Treated With Adjuvant Chemoradiation: A Prospective Validation by RTOG 9704
Adam C. Berger et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial
Viviane Hess et al.
LANCET ONCOLOGY (2008)
Long-Term Survival (5-20 Years) After Pancreatectomy for Pancreatic Ductal Adenocarcinoma A Series of 30 Patients Collected From 3 Institutions
Mustapha Adham et al.
PANCREAS (2008)
Pancreatic adenocarcinoma: The actual 5-year survivors
Cristina R. Ferrone et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Current concepts - Computed tomography - An increasing source of radiation exposure
David J. Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Perioperative mortality for pancreatectomy - A national perspective
James T. McPhee et al.
ANNALS OF SURGERY (2007)
A new approach to managing intraductal papillary mucinous pancreatic neoplasms
Paula Ghaneh et al.
GUT (2007)
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer
Chang Moo Kang et al.
JOURNAL OF SURGICAL RESEARCH (2007)
ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer
Gershon Y. Locker et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection
Mark Bloomston et al.
PANCREAS (2006)
Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma
Cristina R. Ferrone et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular markers of early pancreatic cancer
M Goggins
JOURNAL OF CLINICAL ONCOLOGY (2005)
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma
AC Berger et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Hospital volume and surgical mortality in the United States.
JD Birkmeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials
AG Renehan et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Bowel surveillance patterns after a diagnosis of colorectal cancer in Medicare beneficiaries
KB Knopf et al.
GASTROINTESTINAL ENDOSCOPY (2001)
Share Paper
